Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group

Autor: Arnold, D., Höhler, T., Dittrich, C., Lordick, F., Seufferlein, T., Riemann, J., Wöll, E., Herrmann, T., Zubel, A., Schmoll, H.-J. *
Zdroj: In Annals of Oncology August 2008 19(8):1442-1449
Databáze: ScienceDirect